Athenex
Buffalo
About Athenex
Athenex focuses on the development and commercialization of therapies for cancer and immunomodulatory diseases. Its mission is to become a global leader in bringing innovative cancer treatments to the market and improve health outcomes. The company was founded in 2003 in Buffalo, New York, and has since grown to have operations across the U.S., China, Hong Kong, Taiwan, and the U.K.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Delisted
- Employees: 251 – 500
- Estimated revenue: $50K – $100K
- Total funding: $392.1M
- Funding stage: IPO
- Last round: Post-IPO Equity (Aug 2022)
- Ticker: nasdaq:ATNX
- Website: athenex.com
- Phone: 716-427-2950
Industries & Categories
Biotechnology, Manufacturing, Medical, Pharmaceutical, Retail
Social Profiles
Canonical: https://fsome.com/organization/athenex-90850 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.